Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study) [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial (D-clear) evaluating the efficacy and safety of Libevitug in adults with chronic hepatitis D infection. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Libevitug

Snippet

Sponsor: Huahui Health | Conditions: Chronic Hepatitis D Infection | Phase 3 | Status: NOT_YET_RECRUITING